Security key
004397105
- Security type / class
- Equity / Common Stock
- Total 13F shares
- 75,718,549
- Total 13F value
- $481,919,464
- Share change
- -3,467,511
- Put/Call ratio
- 73%
- SEC-reported price per share
- $6.37
- Number of holders
- 127
- Value change
- -$16,841,819
- Number of buys
- 68
- Number of sells
- 51
- Shares outstanding
- 138,263,204
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q3 2016
Institutions
127
Top holders
10
ARAY full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q4 2016
Previous quarter: Q2 2016
ACCURAY INC SEC filings
ACCURAY INC company facts
Broader feeds
Reporting periods
Holder history for CUSIP 004397105
Recent filing periods:
Ownership snapshot
Top reported holders of ARAY - ACCURAY INC - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
PRIMECAP MANAGEMENT CO/CA/
Disclosed value leader
PRIMECAP MANAGEMENT CO/CA/
Comparable rows
15/15
Latest evidence
30 Jun 2016
13F
Lead comparable stake: 6.2%
Showing 1-6 of 15 holder rows.
Quick read
PRIMECAP MANAGEMENT CO/CA/ leads the comparable SEC ownership view at 6.2%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens PRIMECAP MANAGEMENT CO/CA/'s linked filing trail.
Comparable ownership
Top 5
PRIMECAP MANAGEMENT CO/CA/
6.2%
PFM Health Sciences, LP
4.2%
VANGUARD GROUP INC
4.2%
Boston Partners
3.3%
Neuberger Berman Group LLC
2.4%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| PRIMECAP MANAGEMENT CO/CA/ |
13F
Company
|
6.2%
|
$44,234,000
8,523,000 shares
|
— | 30 Jun 2016 |
| PFM Health Sciences, LP |
13F
Company
|
4.2%
|
$30,002,000
5,780,693 shares
|
— | 30 Jun 2016 |
| VANGUARD GROUP INC |
13F
Company
|
4.2%
|
$29,817,000
5,745,080 shares
|
— | 30 Jun 2016 |
| Boston Partners |
13F
Company
|
3.3%
|
$23,653,000
4,557,399 shares
|
— | 30 Jun 2016 |
| Neuberger Berman Group LLC |
13F
Company
|
2.4%
|
$17,283,000
3,330,140 shares
|
— | 30 Jun 2016 |
| RENAISSANCE TECHNOLOGIES LLC |
13F
Company
|
2.4%
|
$17,226,000
3,319,000 shares
|
— | 30 Jun 2016 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q3 2016
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
127
Shares
75,718,549
Rows available
127
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q3 2016 vs Q2 2016 Across Filers
Q2 2016 holders
131
Q3 2016 holders
127
Holder diff
-4
| Investor | Q2 2016 Shares | Q3 2016 Shares | Share Diff | Share Chg % | Q2 2016 value | Q3 2016 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend